Benjamin Scruggs
Vorstandsvorsitzender bei Altis Biosystems, Inc.
Aktive Positionen von Benjamin Scruggs
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Private Equity Investor | 01.01.2021 | - |
Private-Equity-Analyst | 01.01.2016 | 01.01.2021 | |
IMMvention Therapeutix, Inc.
IMMvention Therapeutix, Inc. BiotechnologyHealth Technology IMMvention Therapeutix, Inc. is an American biotechnology company that develops therapies. The company was founded by Jenny Ting and the CEO is Anil K. Goyal. | Direktor/Vorstandsmitglied | - | - |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Direktor/Vorstandsmitglied | 01.06.2021 | - |
Tune Therapeutics, Inc.
Tune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tune Therapeutics, Inc. is a genetic medicine company based in Durham, NC. Tune Therapeutics is pioneering a new therapeutic modality with its versatile and powerful tempo epigenomic control platform. The platform has the potential to fine-tune any gene network and unlock the full power and potential of regenerative medicine. The company is driving through an inflection point in the history of genetic medicine by addressing thousands of common and complex diseases for which no curative treatment is available. Tune Therapeutics pioneers next-generation genetic therapies by exploring epigenomic control for discovering novel targets that are inaccessible to other approaches. The company was founded in 2020 by Fyodor Urnov, Akira Matsuno, Charles A. Gersbach. The CEO is Matt Kane. | Direktor/Vorstandsmitglied | 01.01.2022 | - |
Altis Biosystems, Inc.
Altis Biosystems, Inc. Miscellaneous Commercial ServicesCommercial Services Altis Biosystems, Inc. operates as a biotechnology company. It develops patent-pending stem cell technology that recreates the human intestinal epithelium. The firm offers products such as RepliGut Planar and RepliGut Crypt. The company was founded by Michael Biron, Christopher Sims, Nancy Allbritton, Scott Magness and Yuli Wang and is headquarterd in Chapel Hill, NC. | Direktor/Vorstandsmitglied | 01.02.2023 | - |
Vorstandsvorsitzender | 01.02.2023 | - |
Karriereverlauf von Benjamin Scruggs
Ausbildung von Benjamin Scruggs
Vanderbilt University | Undergraduate Degree |
Washington University in St. Louis | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Director/Board Member | 4 |
Private Equity Analyst | 1 |
Private Equity Investor | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Finance |
IMMvention Therapeutix, Inc.
IMMvention Therapeutix, Inc. BiotechnologyHealth Technology IMMvention Therapeutix, Inc. is an American biotechnology company that develops therapies. The company was founded by Jenny Ting and the CEO is Anil K. Goyal. | Health Technology |
Veralox Therapeutics, Inc.
Veralox Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Veralox Therapeutics, Inc. develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type 1 diabetes. The company was founded by Jeffrey W. Strovel, David J. Maloney and Matthew B. Boxer and is headquartered in Frederick, MD. | Health Technology |
Tune Therapeutics, Inc.
Tune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tune Therapeutics, Inc. is a genetic medicine company based in Durham, NC. Tune Therapeutics is pioneering a new therapeutic modality with its versatile and powerful tempo epigenomic control platform. The platform has the potential to fine-tune any gene network and unlock the full power and potential of regenerative medicine. The company is driving through an inflection point in the history of genetic medicine by addressing thousands of common and complex diseases for which no curative treatment is available. Tune Therapeutics pioneers next-generation genetic therapies by exploring epigenomic control for discovering novel targets that are inaccessible to other approaches. The company was founded in 2020 by Fyodor Urnov, Akira Matsuno, Charles A. Gersbach. The CEO is Matt Kane. | Health Technology |
Altis Biosystems, Inc.
Altis Biosystems, Inc. Miscellaneous Commercial ServicesCommercial Services Altis Biosystems, Inc. operates as a biotechnology company. It develops patent-pending stem cell technology that recreates the human intestinal epithelium. The firm offers products such as RepliGut Planar and RepliGut Crypt. The company was founded by Michael Biron, Christopher Sims, Nancy Allbritton, Scott Magness and Yuli Wang and is headquarterd in Chapel Hill, NC. | Commercial Services |
- Börse
- Insiders
- Benjamin Scruggs
- Erfahrung